May
Germany, Austria and Switzerland – Market Access Made Simple
Clear insight into payer pathways and decision-making across Germany, Austria and Switzerland
Join global market access expert Andrew Mumford for a practical guide to navigating payer pathways across the region. Gain clarity on how decisions are made, who holds influence and what strategies can speed patient access to innovative medicines.
June
Introduction to Global Market Access Trends
A real-time global review of market access pressures, policy shifts and payer priorities heading into late 2026
What’s really shifting in global market access, and where are the fundamentals holding firm? Join Neil Grubert for a practical, experience-led view of the trends influencing pricing, reimbursement and access decisions across key global markets as 2026 progresses.
Optimising the Benefit of Secondary Prevention: An LSE case study
Using population health, patient stratification and real-world evidence to optimise secondary prevention
How can Life Sciences better identify and treat the patients who benefit most from secondary prevention? In this 60-minute masterclass, LSE Professor Panos Kanavos explores how population health analytics, integrated care pathways and real-world uptake data can optimise access and outcomes.